ch 12 GU GYN Flashcards

1
Q

physiologic leukorrhea

A

physiologic; white clear flocculent discharge
-normal/healthy women of reproductive age
-1-2 tsp/day (antimicrobial/viral properties)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vaginal pH

A

3.8-4.2
lactobiacilli makes lactic acid and Hydrogen peroxide and kills pathogens; resist infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

white curdy cottage cheese discharge

A

candida vulvovaginitis (candida albicans)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

candida vulvovaginitis: patient complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

itching/burning discharge
pH: < 4.5 (usually)
KOH: absent
Micrscope: mycelia, budding yeast pseudohyphae with kOH prep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

candida vulvovaginitis intervention

A

-azole antifungal (oral fluconazole [Diflucan] or vaginal miconazole [Monistat], terconazole [Terazol])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bacterial vaginosis (BV) discharge

A

thin, homogenous. white gray, adherent, often increased
-overgrowth of bacterial that exists in the vagina
etiology: unclear, likely polymicrobial a/s wit hG. vaginalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bacterial vaginosis patient complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

foul odor, itching sometimes, discharge
pH? 5-7 (less lactobacilli to make the acid environment)
KOH: Present (fishy)
Microscopic exam on saline wet mount? >20 clue cell (vaginal epithelial cells) and few WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bacterial vaginosis intervention

A

metronidazole (Metrogel) or oral Flagyl
clindamycin vaginal cream
ovules (Cleocin, oral tinidazole (Tindamax)
oral secnidazole (Solosec $$$)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

genitourinary syndrome of menopause (GSM) aka atrophic vaginitis
etiology? discharge?

A

-estrogen deficiency; women after menopause
-discharge is less and is scant, white clear
-more prone to infections and STI’s
-reversible with supplemental estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GSM aka atrophic vaginitis complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

itching/burning (can be entire urethra region but not UTI), discharge, but can have no sx’s
- > 5 (once estrogen leaves, lactobacilli leaves)
-KOH absent
-few lactobacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GSM aka atrophic vaginitis intervention

A

give topical and/or vaginal estrogen IF symptomatic and/or recurrent UTI
if estrogen lvls go down= lacto goes down and includes urethra region. using topical estrogen, lacto recolonizes = fewer UTI

oral estrogen ALONE is NOT effective , can be effective WITH topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

human herpes virus/herpes simplex 2
clinical findings

A

genital herpes
-with initial outbreak, painful ulceratedlesions, marked lymphadenopathy (ie: L mark inguinal lymphadenopathy if L labial ulcer)
-women: thin vaginal discharge if lesion IN vagina or introitus
-can be few lesions, sx’s vary
-can transmit even if asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

herpes simplex 2 intervention

A

1st line: oral valacylovir (Valtrex)
-acyclovir (Zovirax)
-famciclovir (Famvir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nongonococcal urethritis and cervicitis clinical findings

A

-irritative voiding sx’s; occassional mucopurulent discharge
-women: cervicitis common
-often w/o sx’s regardless of gender
-culture to see large # of WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nongonococcal urethritis and cervicitis treatment

A

1st line: doxycycline 100 mg PO BID x 7 days
alt: azithromycin 1 g PO x1 or levofloxacin 500 mg PO QD x 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nongonococcal urethritis and cervicitis organisms

A

chlamydia trachomatis
ureaplasma urealyticum
mycoplasma genitalium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

gonococcal urethritis and vaginitis causative organism

A

neisseria gonorrhaoeae (Gram - bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

gonococcal urethritis and vaginitis clinical findings

A

irritavei voiding sx’s, occasional purulent discharge
often w/o sx’s
-large # of WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

gonococcal urethritis and vaginitis treatment

A

1st line: ceftriazone 500 mg IM x 1 PLUS doxycycline 100 mg PO BID x 7 days IF chlamydia trachomatis infection has NOT been ruled out

alternative if cef not available: gentamicin 240 mg IM x1, azithromycin 2 g PO as single dose, or cefixime 800 mg PO x1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

trichomoniasis organism

A

trichomonas vaginalis (protozoan)
(protozoan pathogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

trichomoniasis clinical finding

A

dysuria
itching
vulvovaginal irritation
frothy yellow-green vaginal discharge (only 30% have tho)
strawberry spots: cervical petechial hemorrhage (only 30% have tho)
often NO symptoms

motile organisms and lots of WBC
alkaline pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

trichomoniasis intervention

A

1st line:
female: metronidazole 500 mg PO BID x 7 days
males: metronidazole 2 g PO x 1
[not gel; need oral]

alt: tinidazole 2 g PO x 1
EDUCATE NO ALCOHOL FOR 24 HRS after metronidazole completion (abdominal pain!) or 72 hrs after completion of tinidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

most chamydial infections occur in what age groups

A

teen and < 25 yrs old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

acute UNcomplicated UTI (cystitis, urethrtis) in non pregnant women organisms

A

E. coli (gram - ) 75% of all UTI’s
Klebseilla
S saprophyticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
acute UNcomplicated UTI (cystitis, urethrtis) in non pregnant women treatment
-if local E. coli resistance to TMP/SMX < 20% and no allergy, then give TMP/SMX-DS PO BID x 3 days or ***choose-if local E coli resistance to TMP/SMX > 20% or sulfa allergy, give nitrofurantoin (Macrobid) 100 mg PO BID x 5 days -ADD urinary analgesic phenazopyridine (Pyridium) PO for sx control (urethra inflammation lingers even after day 2 of therapy) 2nd line: levofloxacin, Augmentin, ciprofloxacin, cephalexin,
26
which medication can't be given if pt is allergic to sulfa?
bactrim (TMP-SMX)
27
epididymo-orchitis in those 35 and under years old, most likely what organisms?
N gonorrhoeae Chlamydia trachnomatis
28
epididymo-orchitis clinical presentation
irritive voiding sx's (frequency, hematuria, dysuria) fever, painful swelling of epididymis and scrotum -infertility potential post infection
29
epididymo-orchitis treatment under 35 yrs old
ceftriaxone 500 mg IM x 1 PLUS doxycycline 100 mg PO BID x 10 d -educate scrotal elevation to help with symptom relief (Preh's sign)
30
Preh's sign
relief of discomfort with scrotal elevation
31
epididym-orchitis over 35 years old or anal sex partern, most likely organism?
entrobacteriaceae (coliforms) (think lower GU organsms) exact same sx's and infertility potential
32
epididym-orchitis over 35 years old or anal sex partner treatment
Levofloxacin 750 mg PO QD or ofloxacin 300 mg PO BID x 10-14 days
33
acute bacterial prostatits (< 35 years old) organisms & sx's
N gonorrhoeae Chamlydia trachomatis -irritive voiding sx's -suprapubic, perineal pain -fever -tender, boggy prostate from DRE -leukocytosis
34
acute bacterial prostatitis (<35 years old) treatment
ceftriaxone 500 mg IM x1 or cefixime 400 mg PO x1 THEN doxycycline 100 mg PO BID x10 days
35
acute bacterial prostatitis (uncomplicated disease in men with low risk for STI) organism
enterobacteriaceae (coliforms) older men -irritive voiding sx's, suprapubic, perineal pain, fever, -tender, boggy prostate from DRE -leukocytosis
36
acute bacterial prostatitis ( >35; uncomplicated disease in men with low risk for STI) treatment
ciprofloxacin or levofloxacin or TMP-SXM
37
epididymo-orchitis or prostatitis? or both irrititive voiding sx's? perineal pain (hurts when sit on chair)? prehn's sign? usu with fever? scrotal swelling?
irrititive voiding sx's? both perineal pain (hurts when sit on chair)? prostatitis prehn's sign? Epididymo-orchitis usu with fever? both scrotal swelling? Epididymo-orchitis
38
balanitis
inflammation/swelling of head of penis
39
genital candida albicans in men
balanitis groin fold involvement scrotal excoriation
40
tinea cruris
aka jock itch red rash upper bilateral thighs, groin, or vulva involvement ONLY
41
benign prostatic hyperplasia (BPH) sx's & management
lower urinary tract sx's (nocturia, weak stream, urgency, incontinence, voiding difficulties) - get UA, PSA -alpha 1 receptor blockage (tamsulosin)
42
normal prostate physical finding
firm (touching tip of nose), smooth, non tender
43
acute prostatitis DRE finding
tender, boggy, indurated (as firm as touching skin of cheekbone)
44
prostate cancer DRE finding
nodular, firm, nontender -malignant lesions are usu NOT palpable until advanced
45
loss of urine with lifting, coughing, sneezing
stress incontinence
46
transient continence -there was an underlying condition
47
urge incontinence -sudden onset; overactive detruser muscle
48
81 year old in wheelchair can't use toilet w/o assistance
functional incontinence -consider other meds like diuretics and wheelchair
49
urge incontinence
-most common in older adults -strong sensation of needing to empty bladder that cannot be suppressed -involuntary loss of urine
50
urge incontinence management
antimuscarinic (anticholinergic): tolterodine (Detrol), oxybutynin (Ditropan), solifenacin succinate (VESIcare), darifenacin (Enablex), fesoterodine fumarate (Toviaz) AE: dry mouth, sedation, mental status change (in higher doses) alts: Beta agonists: mirabegron (Myrbetriq), vibegron (Gemtesa) and botox injections to bladder
51
stress incontinence
most common in women (men rare) loss of urine with activity that causes inc and pressure (coughing, sneezing, exercise)
52
functional incontinence management
having an assistance who can recognize voiding cues and help with toileting activities
53
stress incontinence management
-support area via vaginal tampon, urethral stents, periurethral bulking agent injections, and pessary -kegal exercises most helpful in younger, premenopausal women -pelvic floor rehab with electrical stimulation and bladder training -surgical intervention
54
functional incontinence
inability to get to toilet or lack of awareness of need to void -usu in mobility issues or altered cognition -worsen by unavailability of a hleper to assist in toileting activities
55
transient incontinence
-a/s with acute events (delirium, UTI, med use, restricted activity)
56
transient incontinence management
treating underlying process, discontinuation of offending medication
57
treatable causes of urinary incontinence
DIAPPERS -delirium -infection (urinary) -atrophic urethritis and vaginitis -pharmaceuticals (diuretics, others) -psychologic disorders (depression) -excessive urine output (heart failure, hyperglycemia due to undetected or poorly controlled DM) -restricted mobility -stool impaction
58
no pap smears needed if
total hysterectomy including cervix
59
if a pt acquires 1 hpv type (genital warts which is 6 & 11)
they're more likely to get other types of HPV
60
ovarian risk factors
post menopausal (older age) obesity nulliparity or 1st preg > 35 years fertility drugs using estrogen post menopause (>5-10 years) family hx/genetics (BRCA1, BRCA2) shared etiology with breast cancer
61
ovarian cancer sx's
non specific sx's in early stage -esp 50yrs old+x -bloating -bladder pressure, constipation, vaginal bleeding, indigestion, SOB, lethargy, weight loss
62
ovarian cancer management
abdominal CT with contrast and pelvis, US, MRI -tumor marker (cancer antigen 125) -surgery then chemo
63
cervical cancer causes
persistent infection with HPV: 70% are HPV 16 & 18 ~20% HPV 31, 33, 52, 58
64
cervical cancer clinical presentation
abnormal vaginal bleeding vaginal discomfort during sex malodour discharge, dysuria typically asx with 1st abnormal pap result
64
cervical cancer diagnostics and tx
pap test then colposcopy and bx -pelvic CT and/or MRI or PET scan -tx based on cancer stage -surgery for early stage -radiation /chemo for advanced
65
endometrial cancer risk factors
older age estrogen therapy nulliparity tamoxifen use (cancer risk < 1% per year) hx of breast or ovarian cancer PCOS DM 2 family hx
66
endometrial cancer clinical presentation
abnormal vaginal bleeding (post menopausal bleeding; or heavy frequent menstrual periods or intermenstrual bleeding in pre/perimenopausal women)
67
endometrial cancer diagnostics
-transvaginal U/S -hydroultrasonography -hysterectomy -endometrial biopsy -fractional D&C
68
endometrial cancer treatment
surgery then chemo w/ or w/o radiation
69
cervical cancer screening in what ages?
start age 21 or 25 and stop 65 yrs
70
do women with hysterecomy need cervical cancer screening?
total hysterecomty with cervical removal can stop UNLESS hysterectomy was for cervical cancer or precancer (CIN 2 or 3) -but if have hysterectomy with cervix still intact, continue screening guidelines
71
women with hx of CIN 2 or CIN 3
continue cervical screening for at least 20 yrs (more frequent the first few yrs to make surer all cancer cells were removed)
72
anal testing in men and women
routine testing NOT rec if asx -test high risk: HIV, anal sex, hx of anal warts, hx of cervical or vulvar cancer -test every year for HIV + and every 2-3 yrs for HIV negative
73
antiretroviral therapy (ART)
HIV care in all adults/adolescents that are HIV + -start ASAP after diagnosing -lifelong
74
preexposure prophylaxis (PrEP)
use of ART for high risk of being infected but don't have HIV (sex, injection) -start ASAP after a risk behavior assessment that determines they're high risk of HIV and lab testing confirms absence of HIV infection -daily treatment until risk of HIV is low from less exposure
75
Postexposure prophylaxis (PEP)
use of ART after a single high risk event exposure (within 72 hrs) to minimize possibility of HIV seroconversion -duration: 28 days